Recruiting
Phase 1

A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

Sponsor:

Novartis Pharmaceuticals

Code:

NCT05462873

Conditions

Carcinoma, Non-Small-Cell Lung

Carcinoma, Renal Cell

Esophageal Squamous Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

QEQ278

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information